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SUMMARY Skin disorders such as acne, which have significant cos-
metic implications, can affect the self-perception of cutaneous body 
image. There are many scales which measure self-perception of cuta-
neous body image. We evaluated the use of a simple Cutaneous Body 
Image (CBI) scale to assess self-perception of body image in a sample 
of young Arab patients affected with acne. A total of 70 patients with 
acne answered the CBI questionnaire. The CBI score was correlated with 
the severity of acne and acne scarring, gender, and history of retinoids 
use. There was no statistically significant correlation between CBI and 
the other parameters – gender, acne/acne scarring severity, and use of 
retinoids. Our study suggests that cutaneous body image perception 
in Arab patients with acne was not dependent on variables like gender 
and severity of acne or acne scarring. A simple CBI scale alone is not 
a sufficiently reliable tool to assess self-perception of body image in 
patients with acne vulgaris.
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IntRodUCtIon
Acne vulgaris is usually a self-limited condition, 
with gradual improvement and spontaneous disap-
pearance after several years, but it may persist into 
the thirties and forties. Severe acne is associated with 
increased depression, anxiety, poor self-image, and 
poor self-esteem. These can be directly or indirectly 
related to factors such as the severity of acne, severity 
of scarring, and medications like retinoids (1).
Different measures have been used to assess the 
psychological impact of acne, including body image 
perceptions. However, most of these scales are cum-
bersome and difficult to administer in an out-patient 
setting. Our study aims to assess the use of a simple 
cutaneous body image score in evaluating the psy-
chological impact of acne.
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table 2. Acne scarring severity scores*
0 Clear. No lesions Residual pigmentation and erythema may be seen
1 Almost clear. Almost no lesions A few scattered open or closed comedones and very few papules
2 Mild
Easily recognizable: less than half of the face is involved. A few open or 
closed comedones and a few papules and pustules
3 Moderate
More than half of the face is involved. Many papules and pustules, 
many open or closed comedones. One nodule may be present
4 Severe
Entire face is involved, covered with many papules and pustules, open 
or closed comedones and rare nodules
5 Very severe Highly inflammatory acne covering the face with presence of nodules
*According to Goodman and Baron (2).
SUBjECtS And MEthodS
The study was a cross-sectional study conducted 
in the out-patient department of a university health 
clinic in the period from January 2012 to May 2012. 
The inclusion criteria were age 15 years and older 
being capable of giving informed consent and a di-
agnosis of acne vulgaris lasting at least five years, 
with a minimum Acne Scarring Severity score (ASS) 
(2) and Global Acne Severity Assessment score (GAS) 
(3) of 1 (Table 1, 2). Patients younger than 15 years 
were excluded from the study, as were patients with 
a known previous diagnosis of significant psychiatric 
co-morbidity. Patients on medication known to in-
duce acneiform eruptions (like corticosteroids) were 
also excluded from the study.
Self-perception of cutaneous body image was as-
sessed using the standardized and validated transla-
tion of the Cutaneous Body Image (CBI) questionnaire 
(4) (Table 3). 
The questionnaire also included socio-demo-
graphic information, history of medication (including 
present treatment with retinoids), and co-morbidi-
ties. GAS and ASS were assessed by a trained derma-
tologist.
The total and average CBI score were correlated 
with four parameters – sex, use of retinoids, GAS, and 
ASS. Pearson’s correlation co-efficient was used for 
evaluating the significance of correlation (a P-value 
of 0.05 was considered significant). Statistical analy-
sis was done using SPSS16 (IBM, Armonk, New York, 
USA).
Ethical permissions were obtained from the clinics’ 
authorities as well as our institution after approval of 
the proposal and data collection tools. Consent forms 
were obtained from patients after they received ad-
equate information about the study. Data confiden-
tiality was maintained throughout the study. The 
patients who volunteered to participate were given 
the questionnaire; and a trained nurse explained the 
items on the questionnaire to the patient. The study 
took place in the dermatology clinic of a university 
health center, and the procedure was supervised by 
the dermatologist who was a member of the research 
team. The other members of the research team in-
cluded a psychiatrist (Mostafa Amr) and a statistics 
expert (Tarek Shams).
RESUltS
The questionnaire was completed by 70 patients. 
There were 39 (55.7%) women and 31(44.3%) men 
with an age range of 15 to 35 years (mean ± SD: 21.0 
± 2.9). All the patients had acne for a period of more 
than 5 years. The mean score for Global Acne Sever-
ity Assessment (GAS) was 2.48 (SD=1.22) and the 
mean score for the Acne Scarring Severity was 1.67 
(SD=0.77). Severe ASS was diagnosed in 17% of the 
patients, and the remaining had mild or moderate 
subtypes. 80% of the patients had mild to moder-
ate GASS and the remaining had severe subtypes. 
Systemic retinoids were used for the treatment of 24 
patients (34.3%). CBI total scores ranged from 32 to 
63 (mean ± SD: 50.8 ± 7.6). The mean CBI individual 
items (1, 3) that were 6.99 ± 1.86 and 6.9 ± 1.81 re-
spectively.
Correlation analysis of the CBI score with GAS, ASS, 
gender, and use of retinoids was done using the Pear-
son Correlation Coefficient (Table 4). There was no sig-
nificant correlation between the total CBI score or the 
individual items and any of the other parameters.
table 1. Global acne severity scale*
Grade 1 Macular scarring
Grade 2 Mild atrophy or hypertrophic scarring that 
may not be evident at 50 cm distance or 
greater and may be adequately masked by 
makeup or hair patterns 
Grade 3 Moderate atrophic or hypertrophic scarring 
obvious at social distances and not easily 
masked 
Grade 4 Severe atrophic or hypertrophic scarring
*According to Dréno et al. (3)
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dISCUSSIon
Cutaneous body image may be defined as the 
individual’s mental perception of the appearance of 
their integumentary system, i.e., their skin, hair, and 
nails (4). This image can be disturbed when there is a 
discrepancy between a person’s self-perception and 
observed interpersonal experiences. Cutaneous body 
image is an important dermatologic construct, which 
can be affected when individuals have a cosmetically 
disfiguring skin disease or when they believe they 
have skin diseases (4). Patient dissatisfaction with 
cutaneous body image is often the primary consider-
ation in deciding whether or not to initiate treatment 
in some skin disorders (5). In this study, we empiri-
cally examined the predictors of cutaneous body im-
age among a sample of Arab patients with acne in a 
University clinic in Saudi Arabia.
Our study demonstrated that there was no signifi-
cant correlation correlation between overall CBI score 
and gender, use of retinoids, GAS, or ASS. Our results 
suggest that cutaneous body image, while definitely 
being useful to study the psychological impact of 
some dermatological conditions, is of questionable 
utility in the case of acne with or without scarring.
Acne vulgaris are more common in men than in 
women (6). The lack of correlation between gender 
and CBI in our study contradicts the findings of Dal-
gard et al. (7), in their survey of self esteem and body 
satisfaction among 3775 late German adolescents. 
They reported that adolescents with acne had poor 
body satisfaction, with girls expressing even lower 
satisfaction than the boys. This difference in compari-
son with our study may be due to the smaller sample 
size (n=70) in our study, as this increases the possibil-
ity of Type II errors. 
Oral isotretinoin is a vitamin A derivative, mar-
keted as an oral treatment for severe acne (8). In re-
cent years, it has also been used for mild to moderate 
forms of acne (9). Treatment with retinioids was insig-
nificantly correlated with body image dissatisfaction 
in our study, which contradicts earlier research that 
retinioids were associated with an increase in relative 
risk estimates for depression, psychotic symptoms, 
suicide, negative self image, and attempted suicide 
(10,11). In a similar context, a recent study accredited 
by the The Psychodermatology Group of the French 
Dermatology Society showed that psychological dis-
turbances, including depression and other suicidal 
tendencies, are very common during adolescence 
and are clearly increased by acne, particularly where 
they are severe; isotretinoin did not appear to in-
crease this risk (12). In a population-based study of 
the level of knowledge and concerns of acne patients 
about isotretinoin in the Qassim regions, Al-Harbi et 
al. noted that that the majority of acne patients are 
aware of isotretinoin and its side effects and accepted 
this drug well (13). We postulate that in many patients 
the improvement produced by retinoids might actu-
ally contribute to improvement in cutaneous body 
image. 
In our study, the most unexpected finding was 
that the body image satisfaction appeared to be 
unrelated to acne severity (measured by GAS, ASS). 
Previous research suggests that the severity of the 
psychological distress in acne that includes depres-
sion, anxiety, low self-esteem, body image problems, 
self-consciousness, lack of self confidence, and anger 
appears to correlate with the patient’s rating of acne 
severity (14,15). However, the findings in our study 
are consistent with the findings of a recent study in 
which patients with acne showed body image dis-
turbances (defined as a persistent report of dissat-
isfaction, concern, and distress that is related to an 
aspect of appearance and measured by the Body Im-
age Disturbance Questionnaire (BIDQ) (16). The fact 
that except for two items (items 3 and 4), none of the 
other items have a direct significance in acne is the 
other major factor that would probably explain the 
absence of low CBI scores in our study.
Previous studies have suggested that the Arab 
culture generally adopts a more stoic view towards 
purely cosmetic problems. The inadequacy of CBI as 
a method for measuring the body image satisfaction table 3. Cutaneous Body Index (CBI) scale*
Item 1 “I like the overall appearance of my skin’’
Item 2 ‘‘I like my complexion or overall color of my skin’’
Item 3 ‘‘I like the appearance of the skin of my face’’
Item 4 ‘‘I like the complexion or the overall color of the 
skin of my face”
Item 5 ‘‘I am very satisfied with my hair’’
Item 6 ‘‘I am satisfied with the appearance of my 
fingernails’’
Item 7 ‘‘I am satisfied with the appearance of my 
toenails’’
*According to Gupta et al. (4).
CBI CBI 1 CBI 3
Sex (Pearson coefficient) -.058 -.069 .062
Sex – p value .635 .569 .608
GAS (Pearson coefficient) -.048 -.207 -.102
table 4. Correlation analysis of CBI scores with 
gender, Acne Scarring Severity, Global Acne Se-
verity Assessment score, and treatment with reti-
noids
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among Arabs is congruent with the findings of a pre-
vious study that estimated body image in a sample 
of Egyptian post menopausal breast cancer patients 
who failed to show body image distress in evaluative 
component compared to behavior component of 
body image, which reflected actions about or toward 
the body (17). Furthermore, in a cross-sectional study 
of the beliefs, knowledge, and perceptions on acne 
among 700 Saudi students (53.4% were acne suffer-
ers) in Riyadh, Saudi Arabia 62% believed that acne 
are not a serious health problem, whereas 19% ac-
cepted acne as a purely cosmetic problem and were 
more likely to seek advice and treatment by beauti-
cians in cosmetic salons rather than do a medical con-
sultation with dermatologists (18). However, the mild 
form of the illness prevalent in that study (17% of the 
patients had severe ASS, and the remaining had mild 
or moderate subtypes; 80% had mild to moderate 
GASS and the remaining had severe subtypes) may 
have contributed to better CBI. 
ConClUSIon
Our study has several limitations. The sample size 
was small and the study population does not nec-
essarily constitute a good representative sample of 
all patients with acne. A prospective study in which 
body image scores were measured by a combination 
of scales measuring the cognitive, behavioral, and af-
fective aspects would provide a better assessment of 
body image in patients with acne, as opposed to only 
using a satisfaction measure such as CBI. 
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